163,000 results on '"Liver diseases"'
Search Results
202. Screening for Chronic Liver Diseases in General Population (HEPGEN)
203. Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment
204. Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
205. bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
206. MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin (SHIELD)
207. Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
208. Surprise Question in End of Life (SeQuEL) Care and the Effect of Prompting Palliative Care Consultation: End-Stage Liver Disease (SeQuEL)
209. Comparison of ALD, NASH, and Healthy Control Patients
210. GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease (GLP-1 RA)
211. Pattern of Cardiac Arrhythmia in Patients With MASLD
212. Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)
213. Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease
214. Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data (LivSPECTRUS)
215. Perioperative Energy Expenditure in Major Liver Resection (PRO-NRG)
216. Evaluate the Effect of Synbiotics on MAFLD (MAFLD-RCT)
217. Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation (INTERLIVER)
218. A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
219. Impact of Fatty Liver on Hepatitis B Therapy (AV-FLCHB)
220. Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit (HEPSY)
221. Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery
222. Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees
223. Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease (CLUE)
224. HELIO Liver Test Performance Study in China (HEPATIC) (HEPATIC)
225. Genetic Collection Protocol
226. Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment
227. Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
228. InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
229. Effects of High-Intensity Interval Training Exercise in Adolescents With Hepatosteatosis
230. Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
231. Systematic Referral to Alcohol Use Dependency Treatment in Patients With Alcohol-related Liver Disease: a RCT
232. Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy
233. Adding Specialist Palliative Care to Transplantation Pilot Trial (ASPECT-Pilot)
234. Effect of a GnRH Analog on Hepatic Steatosis (EndomMASLD)
235. Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
236. Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through Exercise (THOR-X)
237. Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
238. Intra-Hepatic Microbiota in Alcoholic Hepatitis (HepMAH)
239. Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD)
240. Normothermic Liver Preservation Trial
241. A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)
242. Investigating Myosteatosis in Steatotic Liver Diseases (MYO-SLD)
243. Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load (MAFALDA-R)
244. Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome (LGAS)
245. Liver Health and Metabolic Function in People With Obesity
246. A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers
247. Perirenal Fats of Chronic Kidney Disease in Patients With Fatty Liver Disease.
248. Development of a New Method for Liver Stiffness Measurement Using FibroScan (M148)
249. Reducing Non-Alcoholic Steatohepatitis (RedNASH)
250. A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Nonalcoholic Fatty Liver Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.